US brand comparison

Wegovy vs Wegovy HD

Last updated

In STEP UP, a head-to-head trial of the injections, mean weight change was −15.6% on semaglutide (Wegovy) and −18.7% on semaglutide (Wegovy HD) over 72 weeks. These brands contain semaglutide. Compare their approved uses, formulations, and self-pay prices. Products are not interchangeable.

Wegovy vs Wegovy HD: the lowest prices now

Wegovy vs Wegovy HD: active ingredients, formulations, and manufacturers
CompareWegovyWegovy HD
Active ingredientSemaglutideGLP-1SemaglutideGLP-1
How it is taken

Injection

Once weekly

Tablet

Once daily, on an empty stomach

7.2 mg injection

Once weekly

ManufacturerNovo NordiskNovo Nordisk
Direct evidence

What was actually compared

STEP UP (doi.org)

Peer-reviewed paper

Wegovy injection vs Wegovy HD

Adults with a BMI of at least 30, without diabetes.

1,407 participants · 72 weeks (doi.org/10.1016/S2213-8587(25)00226-8) · Randomized, double-blind, with placebo and active control

Mean weight change (% of body weight)

Treatment-policy analysis, accounting for treatment discontinuation.

STEP UP: Mean weight change at 72 weeks. Treatment-policy analysis, accounting for treatment discontinuation.
Treatment & doseChange
Semaglutide (Wegovy)2.4 mg weekly injection−15.6% (doi.org)
Semaglutide (Wegovy HD)7.2 mg weekly injection−18.7% (doi.org)
PlaceboWeekly injection−3.9% (doi.org)

The 7.2 mg dose produced greater mean weight reduction than 2.4 mg or placebo. Gastrointestinal events and altered skin sensations were more frequent at 7.2 mg.

All groups also received a lifestyle intervention. This trial did not study tablets. The 2.4 mg result is from STEP UP, not STEP 1. Study averages do not predict an individual's result.

Read the paper (doi.org)PubMed abstract (pubmed.ncbi.nlm.nih.gov)Reviewed

Weight-loss results by formulation

Each result belongs to its named trial and dose. Separate trials have different participants and methods; these figures are not a direct comparison.

Wegovy vs Wegovy HD: sourced weight-loss results by formulation
CompareWegovyWegovy HD
Injection evidence
−14.9% (nejm.org/doi/full/10.1056/NEJMoa2032183) (-14.9% at 68 wks · STEP 1 · 2.4 mg weekly (Wegovy))

STEP 1 · -14.9% at 68 wks (nejm.org)

2.4 mg weekly (Wegovy)

Accounts for treatment discontinuation

−18.7% (doi.org/10.1016/S2213-8587(25)00226-8) (-18.7% at 72 wks · STEP UP · 7.2 mg weekly (Wegovy HD))

STEP UP · -18.7% at 72 wks (doi.org)

7.2 mg weekly (Wegovy HD)

Accounts for treatment discontinuation

Tablet evidence
−13.6% (nejm.org/doi/full/10.1056/NEJMoa2500969) (-13.6% at 64 wks · OASIS 4 · 25 mg daily (Wegovy tablet))

OASIS 4 · -13.6% at 64 wks (nejm.org)

25 mg daily (Wegovy tablet)

Accounts for treatment discontinuation

No reviewed weight-loss result for this brand and formulation.

Product-specific costs

Entry price and maintenance price

Self-pay quotes, not insurance estimates. Each figure identifies the product, provider, and dose where published.

Wegovy vs Wegovy HD: published self-pay prices by formulation
CompareWegovyWegovy HD
Injection prices

Advertised entry price

$199/fill initially (novocare.com/pharmacy/wegovy.html)

28-day supply (novocare.com)

≈ $213.21 per 30 days at this quoted rate

Offer through

Checked on novocare.com

Wegovy pen (standard doses 0.25-2.4 mg)

NovoCare (Novo Nordisk) · maker's own price

first two 28-day fills at 0.25 or 0.5 mg for new patients; NovoCare: "Offer is for 2 monthly fills through December 31, 2026"

Price conditions

first two 28-day fills at 0.25 or 0.5 mg for new patients; NovoCare: "Offer is for 2 monthly fills through December 31, 2026"

After the introductory offer, standard doses cost $349 per box of four pens, a 28-day supply. Wegovy HD (7.2 mg) is $399. Introductory fills must ship by Jan 31, 2027. Eligibility and restrictions apply.

28-day supply

Published maintenance dose

$349/28 days (novocare.com/pharmacy/wegovy.html)

28-day supply (novocare.com)

≈ $373.93 per 30 days at this quoted rate

Checked on novocare.com

At 2.4 mg

Wegovy pen (standard doses 0.25-2.4 mg)

NovoCare (Novo Nordisk) · maker's own price

Published price at 2.4 mg

Price conditions

Published price at 2.4 mg

After the introductory offer, standard doses cost $349 per box of four pens, a 28-day supply. Wegovy HD (7.2 mg) is $399. Introductory fills must ship by Jan 31, 2027. Eligibility and restrictions apply.

One price for every standard dose (0.25-2.4 mg).

28-day supply

Advertised entry price

$399/28 days (novocare.com/pharmacy/wegovy.html)

28-day supply (novocare.com)

≈ $427.50 per 30 days at this quoted rate

Checked on novocare.com

Wegovy HD pen (7.2 mg)

NovoCare (Novo Nordisk) · maker's own price

self-pay cash, 7.2 mg dose

Price conditions

self-pay cash, 7.2 mg dose

One box holds four single-dose pens, a 28-day supply. 7.2 mg is the Wegovy HD strength; the $199 introductory price applies only to standard Wegovy at 0.25 and 0.5 mg. Prescription, eligibility and restrictions apply.

28-day supply

Published maintenance dose

$399/28 days (novocare.com/pharmacy/wegovy.html)

28-day supply (novocare.com)

≈ $427.50 per 30 days at this quoted rate

Checked on novocare.com

At 7.2 mg

Wegovy HD pen (7.2 mg)

NovoCare (Novo Nordisk) · maker's own price

Published price at 7.2 mg

Price conditions

Published price at 7.2 mg

One box holds four single-dose pens, a 28-day supply. 7.2 mg is the Wegovy HD strength; the $199 introductory price applies only to standard Wegovy at 0.25 and 0.5 mg. Prescription, eligibility and restrictions apply.

28-day supply

Tablet prices

Advertised entry price

from $149/mo (wegovy.com/obesity/what-to-pay-for-wegovy.html)

30-day supply (wegovy.com)

$149 per 30 days at this quoted rate

Checked on wegovy.com

Wegovy pill (oral semaglutide)

NovoCare (Novo Nordisk) · maker's own price

Wegovy pill self-pay at the lowest dose: "Patients pay $149 for each month of 1.5 mg, and $199 per month for 4 mg and $299 per month for 9 mg and 25 mg. One month defined as 1 bottle of 30 tablets."

Price conditions

Wegovy pill self-pay at the lowest dose: "Patients pay $149 for each month of 1.5 mg, and $199 per month for 4 mg and $299 per month for 9 mg and 25 mg. One month defined as 1 bottle of 30 tablets."

$149/mo for 1.5 mg; $199 for 4 mg; $299 for 9 mg and 25 mg. Its plan is one month at a time: "One month defined as 1 bottle of 30 tablets." The Wegovy pen and Ozempic pen offers are left as listed (an introductory price for two fills, then a per-month price).

30-day supply

Published maintenance dose

$299/mo (wegovy.com/obesity/what-to-pay-for-wegovy.html)

30-day supply (wegovy.com)

$299 per 30 days at this quoted rate

Checked on wegovy.com

At 25 mg

Wegovy pill (oral semaglutide)

NovoCare (Novo Nordisk) · maker's own price

Published price at 25 mg

Price conditions

Published price at 25 mg

$149/mo for 1.5 mg; $199 for 4 mg; $299 for 9 mg and 25 mg. Its plan is one month at a time: "One month defined as 1 bottle of 30 tablets." The Wegovy pen and Ozempic pen offers are left as listed (an introductory price for two fills, then a per-month price).

$149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg).

30-day supply

No reviewed tablet formulation in this brand record.

How these quotes are selected

For each price basis, we prefer a recently checked manufacturer-direct quote, then a recently checked provider quote for that brand and formulation. Within each group, documented 30-day costs come first, lowest to highest. Quotes without a documented supply period have no cost rank. Older quotes appear as dated references only when no current quote is tracked. Providers may differ between entry and maintenance prices. Missing maintenance prices are never replaced with entry prices. Compounded products, combined brand quotes, and membership-only fees are excluded. Prices at different doses are not equivalent treatment costs; confirm supply length, eligibility, and added fees.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted maintenance dose is not a dosing recommendation. Our methodology

From FDA and CMS records

Wegovy vs Wegovy HD: timing, generics and coverage

Read from each FDA label, FDA's Orange Book and CMS's Part D files, and updated when they change.

BrandSoonest top doseHalf-lifeGeneric approved?Patent on the medicine toOn Medicare Part D, 2025
Wegovy7.2 mg from week 21about 1 weekNoDec 5, 2031108,843

How long each takes · Generics and patents · Who covers what

US prescribing information

Approved uses by formulation

Eligibility, contraindications, and warnings are in each product's full prescribing information.

Wegovy vs Wegovy HD: reviewed approved uses by formulation
CompareWegovyWegovy HD
Injection

Weight management in eligible adults and adolescents 12+ with obesity; cardiovascular risk reduction in eligible adults; noncirrhotic MASH with moderate to advanced liver fibrosis in adults (accelerated approval).

US prescribing information (novo-pi.com) (Wegovy Injection prescribing information)

Reviewed Nov 4, 2026

Weight management in adults with obesity, or overweight with a weight-related condition. The 7.2 mg dose is for adults who tolerate 2.4 mg and need additional weight reduction.

US prescribing information (novo-pi.com) (Wegovy HD 7.2 mg injection prescribing information)

Reviewed Nov 4, 2026

Tablet

Weight management and cardiovascular risk reduction in eligible adults. The tablet is not labeled for MASH or pediatric use.

US prescribing information (novo-pi.com) (Wegovy Tablet prescribing information)

Reviewed Nov 4, 2026

No reviewed tablet label in this brand record. Ingredient record

Full evidence and safety information

Updated automatically

What changed for Wegovy and Wegovy HD

Written from each source's own record as it changes. Every change on GLPcompare

Questions

Wegovy vs Wegovy HD: common questions

Is Wegovy the same as Wegovy HD?

They contain the same medicine, semaglutide, but they are separate products with their own FDA labels, approved uses and doses, and they are not interchangeable. Wegovy: Chronic weight management (age 12+, injection); cardiovascular risk reduction; MASH with liver fibrosis (injection only). Wegovy HD: Chronic weight management in adults (7.2 mg high-dose injection).

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.